Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer (Q40242985)

http://europepmc.org/abstract/PMC/6295311

1 July 2019

title

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer (English)

1 reference

http://europepmc.org/abstract/PMC/6295311

1 July 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Christopher A. Klebanoff

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sarah R Helman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Harlan Robins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Christian S Hinrichs

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

10

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Anna Pasetto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jared J Gartner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Todd D Prickett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Bryan Howie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Paul F Robbins

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

1 April 2017

1 reference

http://europepmc.org/abstract/PMC/6295311

1 July 2019

published in

Science

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

6334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

200-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Therapeutic vaccination against human papilloma virus induced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Human papillomavirus oncoproteins: pathways to transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Landscape of genomic alterations in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Immunogenicity of somatic mutations in human gastrointestinal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

STAR: ultrafast universal RNA-seq aligner

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Immune epitope database analysis resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAK9510

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

21 January 2018

1 reference

12 December 2020

An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer

1 reference

12 December 2020

Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.

1 reference

12 December 2020

High-throughput pairing of T cell receptor α and β sequences

1 reference

12 December 2020

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases

1 reference

12 December 2020

Identifiers

DOI

10.1126/SCIENCE.AAK9510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28408606%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference